Healthcare and Life Science
BioBeat: Launching the next chapter
BioBeat is joining the One Nucleus hub for life science innovation Cambridge, UK: 23 October 2025The exciting new chapter for BioBeat begins with One Nucleus! BioBeat, connecting entrepreneurs with biotech leaders, is joining the One Nucleus hub for life science innovation. On...
Cambridge tops UK for science investment as US capital surges into tech and life sciences
Cambridge is now the UK’s most investible hub for science, according to a new data report which reveals how the Cambridge region has had the highest growth of any UK region outside the capital in the last decade and attracting unprecedented levels of international capital. ...
OMED Health Partners with Aviva to support the digestive health of employees
75 Aviva employees to gain pilot access to doctor-led OMED Health Plans, which include the use of the OMED Health Breath Analyzer and mobile appCollaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a workplace setting&...
Case study: How Isogenica built its biggest-ever pipeline with 100+% revenue growth
Isogenica, a Cambridge-based biotech pioneering synthetic VHH antibody discovery, went from passive sales and virtually no pipeline to global CRO partnerships, multiple biotech client wins, and the largest commercial pipeline in its history. ...
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR High Complexity Assays
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing ...
ProImmune expands into new 18,000 sq ft global headquarters enabling major expansion in immunology and life science innovation
Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UKIncreased operational capacity enables accelerated development of ProImmune’s REVEAL® Immunogenicity System and Ankyron® target binding technologiesOxford, UK, 22 Oct...
Bio-Rad’s iQ-Check Enterobacteriaceae Kit validated for detection of Enterobacteriaceae in infant formula and cereals
Certified by MicroVal for Detection of Enterobacteriaceae Including Salmonella, Cronobacter, and E.coli as Indicator of Process Effectiveness to Eliminate Contaminants in Infant Formula and Related Ingredients. ...
Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral
Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate2,000 new compounds generated for the programme are now available from Enamine’s catalogueKyiv, Ukraine, 21 October, 202...
Mosaic Therapeutics appoints Thomas Fuchs as CEO
Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadershipAppointment strengthens executive leadership team and supports transition into clinical developmentCambridge, UK, 20 October ...
giles introduces AI agent to accelerate healthcare and life science research
AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articlesgiles will be showcased at ISPOR Europe 2025, Glasgow, 9-12th November, booth 314London, UK, 20 October 2025: gil...